Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Seeta Nyayapathy
Institution:
Cayman Chemical (United States)
Observed institution:
Cayman Chemical (United States)
ORCID:
0009-0002-6585-8676
Observed ORCID:
0009-0002-6585-8676
OpenAlex ID:
A5046458764
Identification of molecularly targeted therapy-induced immunopeptidome in diffuse midline glioma (DMG)
2026
·
Niloofar Khairkhah
, Habeebah Owolabi
, et al.
·
Neoplasia
·
2
Abstract 2996: CT26 neoantigen presentation and immunogenicity
2023
·
Seeta Nyayapathy
, Richard Jones
, et al.
·
Cancer Research
·
1
Abstract 1384: Immunopeptidome analysis of mouse MHC Class I
2022
·
Seeta Nyayapathy
, Richard Jones
, et al.
·
Cancer Research
·
1
Lipid nanoparticle (LNP) components dictate the cellular immune responses to vaccination 3550
2025
·
J Paige Gronevelt
, Avery Blanks
, et al.
·
The Journal of Immunology
PDF
Lipid nanoparticle SARS-CoV-2 vaccine-mediated immunopeptidome identification 4042
2025
·
Julie M. Rumble
, Seeta Nyayapathy
, et al.
·
The Journal of Immunology
PDF
Abstract 3484: Lipid nanoparticle-mediated in vitro transfection of microbubble-activated T cells
2025
·
Seeta Nyayapathy
, Paige Gronevelt
, et al.
·
Cancer Research
Abstract 5248: Identification of a chromatin-remodeling peptide in diffuse midline glioma by immunopeptidomics
2025
·
Niloofar Khairkhah
, Ali Namvar
, et al.
·
Cancer Research
Improved identification of allele-specific MHC class II immunopeptidome
2024
·
Julie Rumble
, Seeta Nyayapathy
, et al.
·
The Journal of Immunology
Show more works
View as search
Works count:
8
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type
